Innovations in engineering and bioprocess development have accelerated the transition of induced pluripotent stem cell (iPSC) cultivation and use from the bench-top to large-scale clinical manufacturing. Owing to their potency, proliferation capabilities, and ability to overcome the challenges associated with traditional sources of pluripotent stem cells (PSCs), iPSCs have generated significant interest in the field of regenerative medicine for more than a decade. However, traditional bench scale methods to expand iPSCs, including petri dishes and T-flasks, are insufficient to achieve clinically relevant numbers. For iPSC treatments, cell dosages will range from 109 – 1012 cells per patient depending on the therapeutic target. To achieve th...
For cultivation of mammalian cells in biopharmaceutical research and manufacturing, single-use techn...
Three-dimensional perfusion bioreactors have been shown to enhance cell viability and function throu...
A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf ce...
Hydrodynamic variables in bioreactors such as velocity, shear rate, and energy dissipation rate have...
Human-induced pluripotent stem cells (hiPSCs) have generated a great deal of attention owing to thei...
There is a growing necessity for cell cultivation using bioreactors to translate laboratory based cu...
Embryonic stem cells have a large potential to help patients with commonly known diseases such as Pa...
Induced Pluripotent Stem Cells (iPSC) are capable of extensive self-renewal while retaining the abil...
Two dimensional (2-D) cell culture technologies have proven inadequate for large scale manufacturing...
Human induced pluripotent stem cells (hiPSC) are attractive tools for drug screening and disease mod...
Human Mesenchymal Stem Cells (hMSCs) are multipotent, immune-privileged, and possess the capacity to...
Over the last decade especially, the promise of stem cell technology to cure a multitude of genetic ...
Abstract To harness the full potential of human pluripotent stem cells (hPSCs) we combined instrumen...
Figure 1 - (a) Pump driven continuous perfusion 3D bioreactor. (b) The 3D bioreactor matrix. (c) Mat...
An ideal, versatile bioreactor for cell and gene therapy should be capable of growing cells across a...
For cultivation of mammalian cells in biopharmaceutical research and manufacturing, single-use techn...
Three-dimensional perfusion bioreactors have been shown to enhance cell viability and function throu...
A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf ce...
Hydrodynamic variables in bioreactors such as velocity, shear rate, and energy dissipation rate have...
Human-induced pluripotent stem cells (hiPSCs) have generated a great deal of attention owing to thei...
There is a growing necessity for cell cultivation using bioreactors to translate laboratory based cu...
Embryonic stem cells have a large potential to help patients with commonly known diseases such as Pa...
Induced Pluripotent Stem Cells (iPSC) are capable of extensive self-renewal while retaining the abil...
Two dimensional (2-D) cell culture technologies have proven inadequate for large scale manufacturing...
Human induced pluripotent stem cells (hiPSC) are attractive tools for drug screening and disease mod...
Human Mesenchymal Stem Cells (hMSCs) are multipotent, immune-privileged, and possess the capacity to...
Over the last decade especially, the promise of stem cell technology to cure a multitude of genetic ...
Abstract To harness the full potential of human pluripotent stem cells (hPSCs) we combined instrumen...
Figure 1 - (a) Pump driven continuous perfusion 3D bioreactor. (b) The 3D bioreactor matrix. (c) Mat...
An ideal, versatile bioreactor for cell and gene therapy should be capable of growing cells across a...
For cultivation of mammalian cells in biopharmaceutical research and manufacturing, single-use techn...
Three-dimensional perfusion bioreactors have been shown to enhance cell viability and function throu...
A scalable biomanufacturing platform is crucial to meet the anticipated demands for off-the-shelf ce...